Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 2;18(1):506.
doi: 10.1186/s12885-018-4420-8.

Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer

Affiliations
Free PMC article

Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer

Soon Auck Hong et al. BMC Cancer. .
Free PMC article

Abstract

Background: Dickkopf-1 (DKK1) is a Wnt/ß-catenin pathway antagonist related to gastric cancer (GC) carcinogenesis. However, the prognostic role of combined DKK1 and ß-catenin expression in advanced GC (AGC) is not clear.

Methods: In total, 158 patients with AGC who underwent gastric resection were enrolled in this study. DKK1 and ß-catenin expression was evaluated in whole tumor sections by immunohistochemistry.

Results: DKK1 expression was high in 73 (46.2%) patients, while ß-catenin expression was positive in 51 (32.3%) patients. The expression of DKK1 was positively correlated with that of ß-catenin (P < 0.001). The combined expression of DKK1 and ß-catenin was significantly associated with high N stage (N2 and N3) (P = 0.042). In addition, patients with high DKK expression demonstrated poorer overall (OS) (P < 0.001) and disease-free survival (DFS) (P = 0.001). However, there were no differences between high DKK1 expression with ß-catenin positivity and high DKK1 expression with ß-catenin negativity (OS, P = 0.379: DFS, P = 0.255). Multivariate analysis revealed that high DKK1 alone or high DKK1 with ß-catenin positivity were independent prognostic factors for both OS (high DKK1: hazard ratio [HR], 2.130; 95% confidence interval [CI]; 1.370-3.312, P = 0.001; high DKK1 with ß-catenin positivity: HR, 2.140; 95% CI, 1.343-3.409: P = 0.001) and DFS (high DKK1: HR, 2.092; 95% CI, 1.180-3.708; P = 0.012; high DKK1 with ß-catenin positivity: HR, 2.357; 95% CI, 1.291-4.306; P = 0.005).

Conclusion: Our results indicate that high DKK1 expression regardless of ß-catenin positivity is a crucial prognostic factor for predicting tumor recurrence and survival in patients with resected AGC.

Keywords: Cut value; Dickkopf-1; Gastric cancer; Prognosis.

PubMed Disclaimer

Conflict of interest statement

Authors’ information

Soon Auck Hong: Clinical Assistant Professor, Department of Pathology, Soonchunhyang Cheonan University Hospital, Cheonan, Republic of Korea.

Soo Hyun Yoo: Pathologist, Medical Clinic Laboratory Department of U2Bio Co. Ltd., Seoul, Republic of Korea.

Han Hong Lee: Associate Professor, Department of General Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Der Sheng Sun: Clinical Associate Professor, Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Hye Sung Won: Associate Professor, Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Okran Kim: Researcher, Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Yoon Ho Ko: Division of Oncology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea and Cancer Research Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Ethics approval and consent to participate

This study was approved by the Institutional Research Ethics Board of Uijeongbu St. Mary’s Hospital of the Catholic University of Korea. Due to the retrospective nature of the study and the fact that no identifiable information is included, informed consent was not required according to laws of the Institutional Research Ethics Board of Uijeongbu St. Mary’s Hospital of the Catholic University of Korea. The project was compliance with the Helsinki Declaration.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Immunohistochemical staining of DKK1 and β-catenin in normal gastric mucosa. Scant expression of DKK1 (a) and membranous staining (b) of β-catenin were observed
Fig. 2
Fig. 2
Expression of DKK1 protein in advanced gastric cancer with N1 and N2 is higher than that in N2 and N3
Fig. 3
Fig. 3
Immunohistochemical staining of DKK1 and β-catenin staining in GC. Representative images of GC with high expression of DKK1 (a), low expression of DKK1 (b), positive β-catenin staining (c), and negative β-catenin staining (d)
Fig. 4
Fig. 4
Kaplan-Meier survival curves were plotted according to DKK1 and β-catenin protein expression. High DKK1 expression was significantly related to poor OS (a) and DFS (b) in GC patients. Patients with positive β-catenin staining showed shorter OS (c), while DFS (d) was not different significantly between patients with positive and those with negative β-catenin staining. The combination of DKK1 and β-catenin expression was evaluated for its impact on OS (e) and DFS (f)

Similar articles

Cited by

References

    1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi: 10.1002/ijc.29210. - DOI - PubMed
    1. Yada T, Yokoi C, Uemura N. The current state of diagnosis and treatment for early gastric cancer. Diagn Ther Endosc. 2013;2013:241320. doi: 10.1155/2013/241320. - DOI - PMC - PubMed
    1. Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol. 2006;24(18):2903–2909. doi: 10.1200/JCO.2005.05.0245. - DOI - PubMed
    1. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell. 2009;17(1):9–26. doi: 10.1016/j.devcel.2009.06.016. - DOI - PMC - PubMed
    1. Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36(11);1461–73. - PMC - PubMed